Recombinant IL2RA (Basiliximab Biosimilar) antibody

Catalog No. ABIN7813166

The Chimeric Chimeric anti-IL2RA (Basiliximab Biosimilar) antibody has been validated for . It is suitable to detect IL2RA (Basiliximab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL2RA (Basiliximab Biosimilar) antibody (ABIN7813166)

Target: IL2RA (Basiliximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This IL2RA (Basiliximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL2RA (Basiliximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Basiliximab Biosimilar - Anti-IL2RA, CD25 mAb - Research Grade

Characteristics: IgG1-kappa

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01M PBS, pH 7.4.

Handling Advice: Avoid repeated freeze-thaw cycles

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles

Expiry Date: 12 months

Target Details for IL2RA (Basiliximab Biosimilar)

Target: IL2RA (Basiliximab Biosimilar)

Alternative Name: Basiliximab Biosimilar

Target Type: Biosimilar

Background: Anti-CD25, Anti-IL2RA, Anti-DHB95812, CHI621, CHI-621 / SDZ-CHI-621, , , DHB95812

UniProt: P01589

CAS-No: CAS: 179045-86-4,CAS: 2417483-64-6